Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Supportive Care in Cancer
Erschienen in: Supportive Care in Cancer 5/2014

01.05.2014 | Review Article

How long do the effects of acupuncture on hot flashes persist in cancer patients?

verfasst von: Jessica W. Frisk, Mats L. Hammar, Martin Ingvar, Anna-Clara E. Spetz Holm

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Acupuncture has been suggested as therapy for hot flashes in women with breast cancer and men with prostate cancer. In this systematic review, we sought to evaluate the long-term effects on vasomotor symptoms after the end of a defined treatment period of acupuncture in women with breast cancer and men with prostate cancer.

Methods

A literature search revealed 222 articles within the field. With defined exclusion criteria, we identified 17 studies. We also used the Jadad quality score and identified seven studies with a score of at least 3.

Results

Six of seven identified studies qualified for inclusion in an analysis that measured frequency of hot flashes weighted in relation to number of patients (n = 172). The average reduction from baseline to end of acupuncture (ranging between 5 and 12 weeks of treatment) showed 43.2 % reduction of hot flashes. At the last follow-up (mean 5.8 months, range 3–9 months) after the end of therapy, the weighted reduction from baseline was sustained at 45.6 % in the 153 of 172 patients (89 %) who were followed up.

Conclusions

Data from six prospective analyzed studies indicate at least 3-month effects after the end of acupuncture treatment for flashes in women with breast cancer and men with prostate cancer. However, larger randomized trials with long-term follow-up will be needed to confirm these preliminary findings.
Literatur
1.
Avis NE, Ory M, Matthews KA et al (2003) Health-related quality of life in a multi-ethnic sample of middle-aged women: study of Women’s Health Across the Nation (SWAN). Med Care 41:1262–1276PubMedCrossRef
2.
Spetz AC, Fredrikson MG, Hammar ML (2003) Hot flashes in a male population aged 55, 65, and 75 years, living in the community of Linkoping, Sweden. Menopause 10:81–87PubMed
3.
Spetz AC, Palmefors L, Skobe S et al (2007) Testosterone correlated to symptoms of partial androgen deficiency in aging men (PADAM) in a Swedish elderly population. Menopause 14:999–1005PubMed
4.
Spetz Holm AC, Fredrikson MG, Theodorsson E et al (2011) Change in testosterone concentrations over time is a better predictor than the actual concentrations for symptoms of late onset hypogonadism. Aging Male 14:249–256CrossRef
5.
Buchholz N-P, Mattarelli G, Huber Buchholz MM (1994) Post-orchiectomy hot flashes. Eur Urol 266:120–122
6.
Frödin T, Ålund G, Varenhorst E (1985) Measurement of skin blood-flow and water evaporation as a means of objectively assessing hot flashes after orchidectomy in patients with prostatic cancer. Prostate 7:203–208PubMedCrossRef
7.
Carpenter JS, Andrykowski MA, Cordova M et al (1998) Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 82:1682–1691PubMedCrossRef
8.
Harris PF, Remington PL, Trentham-Dietz A et al (2002) Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 23:501–509PubMedCrossRef
9.
Carpenter JS, Elam JL, Ridner SH et al (2004) Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 31:591–598PubMedCrossRef
10.
Savard J, Davidson JR, Ivers H et al (2004) The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 27:513–522PubMedCrossRef
11.
Love RR, Cameron L, Connell B et al (1991) Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 151:1842–1847PubMedCrossRef
12.
Day R, Ganz PA, Costantino JP et al (1999) Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel project P-1 Study. J Clin Oncol 17:2659–2669PubMed
13.
Crandall C, Petersen L, Ganz PA et al (2004) Association of breast cancer and its therapy with menopause-related symptoms. Menopause 11:519–530PubMedCrossRef
14.
MacLennan AH, Broadbent JL, Lester S, et al. (2004) Oral oestrogen and combined oestrogen/progestagen therapy versus placebo for hot flashes. Cochrane Database Syst Rev (4):CD002978
15.
Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333CrossRef
16.
Herrington DM, Vittinghoff E, Lin F et al (2002) Statin therapy, cardiovascular events and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 105:2962–2967PubMedCrossRef
17.
Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427PubMedCrossRef
18.
Holmberg L, Iversen OE, Rudenstam CM et al (2008) Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 100:475–482PubMedCrossRef
19.
Charig CR, Rundle JS (1989) Flashing: long-term side effect of orchiectomi in treatment of prostatic carcinoma. Urology 33:175–178PubMedCrossRef
20.
Spetz AC, Hammar M, Lindberg B et al (2001) Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation in metastatic carcinoma of the prostate. J Urol 166:517–520PubMedCrossRef
21.
Karling P, Hammar M, Varenhorst E (1994) Prevalence and duration of vasomotor symptoms after surgical or medical castration in men with prostatic carcinoma. J Urol 152:1170–1173PubMed
22.
Kronenberg F, Fugh-Berman A (2002) Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 137:805–813PubMedCrossRef
23.
North American Menopause Society (2004) Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 11:11–33CrossRef
24.
Mom CH, Buijs C, Willemse PHB et al (2006) Hot flashes in breast cancer patients. Crit Rev Oncol Hematol 57:63–77PubMedCrossRef
25.
Wong VC, Lim CE, Luo X et al (2009) Current alternative and complementary therapies used in menopause. Gynecol Endocrinol 25:166–174PubMedCrossRef
26.
Albertazzi P (2007) Non-estrogenic approaches for the treatment of climacteric symptoms. Climacteric 115–120. doi:10.1080/13697130701440980
27.
Albertazzi P (2006) Noradrenergic andsertonergic modulation to treat vasomotor symptoms. J Br Menopause Soc 12:7–11PubMedCrossRef
28.
Kenemans P, Bundred NJ, Foidart JM et al (2009) Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 10:135–146PubMedCrossRef
29.
Kelly CM, Juurlink DN, Gomes T et al (2010) Selective serotonin reuptake inhibitors and breastcancer mortality in women receiving tamoxifen: a population based cohort study. BMJ 340:693–701CrossRef
30.
Quella SK, Loprinzi CL, Sloan J et al (1999) Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol 162:98–102PubMedCrossRef
31.
Roth AJ, Scher HI (1998) Sertraline relieves hot flashes secondary to medical castrations as treatment of advanced prostate cancer. Psychooncology 7:129–132PubMedCrossRef
32.
Loprinzi CL, Barton DL, Sloan JA et al (2008) Mayo clinic and north central cancer treatment group hot flash studies: a 20-year experience. Menopause 15:655–660PubMedCrossRef
33.
Loprinzi CL, Michalak JC, Quella SK et al (1994) Megestrol acetate for the prevention of hot flashes. N Engl J Med 331:347–552PubMedCrossRef
34.
Thacker H (2011) Assesing risks and benefits of non-hormonal treatments for vasomotor symptoms in perimenopausal women and postmenopausal women. J Womens Health 20:1007–1016CrossRef
35.
Irani J, Salomon L, Oba R et al (2010) Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproteroneactetate for the treatment of vasomotor hot flashes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncol 11:147–154PubMedCrossRef
36.
Frisk J (2010) Managing hot flashes in men after prostate cancer–a systematic review. Maturitas 65:15–22PubMedCrossRef
37.
Andersson S, Lundeberg T (1995) Acupuncture—from empiricism to science: functional background to acupuncture effects in pain and disease. Med Hypotheses 45:271–281PubMedCrossRef
38.
Wyon Y, Lindgren R, Lundeberg T et al (1995) Effects of acupuncture on climacteric vasomotor symptoms, quality of life and urinary excretion of neuropeptides among postmenopausal women. Menopause 2:3–12CrossRef
39.
D’Amico JF, Greendale GA, Lu JK et al (1991) Induction of hypothalamic opoid activity with transdermal estradiol administration in postmenopausal women. Fertil Steril 55:754–758PubMed
40.
Melis GB, Paoletti AM, Gambacciani M et al (1984) Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using Naloxone. Neuroendocrinology 39:60–63PubMedCrossRef
41.
Nedstrand E, Wijma K, Wyon Y et al (2005) Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric 8:243–250PubMedCrossRef
42.
Cohen SM, Rosseau ME, Carey BL (2003) Can acupuncture relieve symptoms of the menopause? Holist Nurs Pract 17:295–299PubMedCrossRef
43.
Porzio G, Trapasso T, Martelli S et al (2002) Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen. Tumori 88:128–130PubMed
44.
Nir Y, Huang MI, Schenyer R et al (2007) Acupuncture for postmenopausal hot flashes. Maturitas 56:383–395PubMedCrossRef
45.
Frisk J, Carlhäll S, Källström A-C et al (2008) Long-term follow-up of acupuncture and hormone therapy on hot flashes in women with breast cancer: a prospective, randomized, controlled multicenter trial. Climacteric 11:166–174PubMedCrossRef
46.
Hammar M, Frisk J, Grimås Ö et al (1999) Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study. J Urol 161:853–859PubMedCrossRef
47.
Frisk J, Spetz AC, Hjertberg H et al (2009) Two modes of acupuncture as a treatment for hot flashes in men with prostate cancer-A prospective multicenter study with long-term follow-up. Eur Urol 55:156–163PubMedCrossRef
48.
Ashmalla H, Jiang ML, Guirguis A et al (2011) Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy. Int J Radiat Oncol Biol Phys 79:1358–1363CrossRef
49.
Baber R, Hickey M, Kwik M (2005) Therapy for menopausal symptoms during and after treatment for breast cancer: safety considerations. Drug Saf 28:1085–1100PubMedCrossRef
50.
Streitberger K, Kleinhenz J (1998) Introducing a placebo needle into acupuncture research. Lancet 352:364–365PubMedCrossRef
51.
Goddard G, Shen Y, Steele B et al (2005) A controlled trial of placebo versus real acupuncture. J Pain 6:237–242PubMedCrossRef
52.
Park J, White A, Stevinson C, Ernst E et al (2002) Validating a new non-penetrating sham acupuncture device: two randomized controlled trials. Acupunct Med 20:168–171PubMedCrossRef
53.
White P, Lewith G, Hopwood V et al (2003) The placebo needle, is it a valid and convincing placebo for use in acupuncture trials? A randomised, single-blind, cross-over pilot trial. Pain 106:401–409PubMedCrossRef
54.
Tsukayama H, Yamashita H, Kimura T et al (2006) Factors that influence the applicability of sham needle in acupuncture trials: two randomized, single-blind, crossover trials with acupuncture-experienced subjects. Clin J Pain 22:346–349PubMedCrossRef
55.
Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12PubMedCrossRef
56.
Deng VA, Yeung S et al (2007) Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. J Clin Oncol 25:5584–5590PubMedCrossRef
57.
Hervik J, Mjåland O (2009) Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial. Breast Cancer Res Treat 116:311–316PubMedCrossRef
58.
Liljegren A, Gunnarsson P, Landgren BM et al (2012) Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial. Breast Cancer Res Treat 135:791–798PubMedCrossRef
59.
Tukmachi E (2000) Treatment of hot flashes in breast cancer patients with acupuncture. Acupunct Med 18:22–27CrossRef
60.
Filshie J, Bolton T, Browne D et al (2005) Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients-audit and treatment algorithm. Acupunct Med 23:171–180PubMedCrossRef
61.
Walker G, de Valois B, Davies R et al (2007) Ear acupuncture for hot flashes—the perceptions of women with breast cancer. Complement Ther Clin Pract 14:250–257CrossRef
62.
Harding C, Harris A, Chadwick D (2008) Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer. BJU 103:186–190CrossRef
63.
64.
de Valois BA, Young TE, Robinson N et al (2010) Using traditional acupuncture for breast cancer-related hot flashes and night sweats. J Altern Complement Med 16:1047–1057PubMedCrossRef
65.
Walker E, Rodriguez A, Kohn B et al (2010) Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol 28:634–640PubMedCrossRef
66.
Otte J, Carpenter J, Zhong X et al (2011) Feasibility study of acupuncture for reducing sleep disturbances and hot flashes in postmenopausal breast cancer survivors. Clin Nurse Spec 25:228–236PubMedCentralPubMedCrossRef
67.
Bokmand S, Flyger H (2013) Acupuncture relieves menopausal discomfort in breast cancer patients: a prospective, double blinded, randomized study. Breast 22:320–323PubMedCrossRef
68.
69.
Freedman R (1989) Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology 26:573–579PubMedCrossRef
70.
Cohen FJ, Lu Y (2000) Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials. Maturitas 34:65–73PubMedCrossRef
71.
Metadaten
Titel
How long do the effects of acupuncture on hot flashes persist in cancer patients?
verfasst von
Jessica W. Frisk
Mats L. Hammar
Martin Ingvar
Anna-Clara E. Spetz Holm
Publikationsdatum
01.05.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2126-2

Weitere Artikel der Ausgabe 5/2014

Supportive Care in Cancer 5/2014 Zur Ausgabe

Original Article

Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

Original Article

Biologically based therapies are commonly self-prescribed by Brazilian women for the treatment of advanced breast cancer or its symptoms

Original Article

The role of complementary and alternative medicine (CAM) routines and rituals in men with cancer and their significant others (SOs): A qualitative investigation

Letter to the editor

Post-radical hysterectomy detrusor dysfunctions: is sacral neurostimulation a valid treatment strategy?

Original Article

Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy

Original Article

Spiritual support of cancer patients and the role of the doctor

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise